Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The aims of our study are to evaluate the feasibility and safety of endoscopic injection of
adipose tissue-derived mesenchymal stem cells in human subjects with moderate active
ulcerative colitis, assessing the absence of adverse events associated to the investigational
drug, and to evaluate the efficacy of the treatment to induce remission of moderate active
ulcerative colitis, by improvements in disease activity index, quality of life index, and
endoscopic index.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Collaborators:
Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz Ministry of Health, Spain